Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraarticular Injections of Steroids, HA, or PRP vs Placebo for Knee Osteoarthritis
NCT02776514Phase 2Completed
- Sponsor
- University Hospital Balgrist
- Start
- Feb 2016
- Primary completion
- Nov 2020
- Modality
- Adipose-derived MSCs, Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of triamcinolone acetonide, platelet-rich plasma and sodium hyaluronate in osteoarthritis (OA) (4 arms), sponsored by University Hospital Balgrist. Primary endpoints: Clinical Outcome (Pain using Numeric Rating Scale) up to 24 months and Magnetic Resonance Imaging (Cartilage Defects) up to 12 months. Started Feb 2016; status: completed.
02
Drugs
triamcinolone acetonideplatelet-rich plasmasodium hyaluronate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02776514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02776514.